Sort   by:  
 Page size 
GenomicsMolecular subtyping of “double negative” MIBC
Molecular subtyping of “double negative” MIBC
PRJNA816119 | ENA
GenomicsKinome expression profiling of muscle invasive bladder cancer (MIBC) patients
Kinome expression profiling of muscle invasive bladder cancer (MIBC) patients
PRJNA541420 | ENA
ProteomicsProteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy
Platinum-based neoadjuvant chemotherapy (NAC) prior to radical cystectomy is the preferred treatment for muscle-invasive bladder cancer (MIBC) despite modest survival benefit and significant associated toxicities. Here, we profiled the global proteome of MIBC tumours pre- and post-NAC treatment usin...
ORGANISM(S): Homo sapiens (Human) 
2025-02-11 | PXD049435 | Pride
Bladder cancer Mibc 
TranscriptomicsKinome expression profiling of muscle invasive bladder cancer (MIBC) patients
Muscle invasive bladder cancer (MIBC) is one of the aggressive cancer with limited treatment options. Targeted gene expression profiling in normal and tumor samples from MIBC patients could aid in identification of potential therapeutic targets. Thus we used kinase specific panel to study their expr...
ORGANISM(S): Homo sapiens 
2020-04-20 | GSE130598 | GEO
TranscriptomicsBladder-RI
A Cartes dM-^RIdentite des Tumeurs (CIT) project from the french Ligue Nationale Contre le Cancer (http://cit.ligue-cancer.net/). Seven transcriptome datasets corresponding to a new series of 85 MIBC (Muscle-invasive bladder cancer) and six publicly-available series (298 MIBC) were analyzed. Tumors ...
ORGANISM(S): Homo sapiens 
2014-06-01 | E-MTAB-1803 | biostudies-arrayexpress
GenomicsmiBC: the mouse intestinal Bacterial Collection
miBC: the mouse intestinal Bacterial Collection
PRJEB11650 | ENA
UnknownThe bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M.
Not available
S-EPMC10282653 | biostudies-literature
TranscriptomicsMolecular subtyping of “double negative” MIBC
Identifying patients that benefit from cisplatin-based adjuvant chemotherapy is a major issue in the management of muscle-invasive bladder cancer (MIBC). The purpose of this study is to correlate “luminal” and “basal” type protein expression with histological subtypes, to investigate the prognostic ...
ORGANISM(S): Homo sapiens 
2022-05-14 | GSE198607 | GEO
UnknownIdentification of a cisplatin resistant-based prognostic immune related gene signature in MIBC.
Not available
S-EPMC10990904 | biostudies-literature
GenomicsNeutrophils and CD8+ T cells in Muscle-invasive Bladder Cancer (MIBC)
Neutrophils and CD8+ T cells in Muscle-invasive Bladder Cancer (MIBC)
PRJNA1307385 | ENA
Sort   by:  
 Page size